Fundz

Syapse Inc. reported raising $20.1 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEMay 06, 2019$20.1M of $30M raised

Amount Raised

$20.1 Million

$20.1 Million sold, per SEC Form D (first sale May 6, 2019)

Round Type

Venture

Palo AltoInformation TechnologyBiotechnologyHealth CareLife Science

Who else raised in Life Science and Biotechnology around the same time

Companies in the same sectors as Syapse Holdings that raised within 45 days of this round, from Fundz verified event records.

  • Lifeward raised an undisclosed amount on June 19, 2019.
  • Lifeward raised $5M on June 19, 2019.
  • Beyond Air raised $8M on June 18, 2019.
  • Prelude Therapeutics Inc raised $30M on June 17, 2019.
  • SpyGlass Pharma, Inc. raised $6M on June 5, 2019.
  • KayoThera, Inc. raised $750K (Seed) on June 5, 2019.

Who to call at Syapse Holdings, and when

A new round usually means Syapse Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Syapse Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syapse Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syapse Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syapse Holdings

Location

101 UNIVERSITY AVENUE

Palo Alto, California, United States

About

Syapse Holdings Inc. is a pioneer in precision medicine solutions for community cancer centers. Its extensive network of community-based health systems, with more than 1,000 oncologists, its data and technology stack, and its dedicated team have been integrated into N-Power Medicine. Syapse’s existing offerings for its health system and pharma partners will be expanded with N-Power’s AI-enabled ‘human-in-the-loop’ approach to significantly expand access to prospective clinical trials and life-saving innovations for patients in community settings.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syapse Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Syapse Holdings's next move

See what Strategic adds

Syapse Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.